• TechCrunch
• CrunchBase
• More
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

Invitrogen

edit

Invitrogen Corporation (NASDAQ: IVGN - News) provides products and services that support academic and government research institutions and pharmaceutical and biotech companies worldwide in their efforts to improve the human condition. The company provides essential life science technologies for disease research, drug discovery, and commercial bioproduction.

Invitrogen’s own research and development efforts are focused on breakthrough innovation in all major areas of biological discovery including functional genomics, proteomics, bioinformatics and cell biology – placing Invitrogen’s products in nearly every major laboratory in the world. Founded in 1987, Invitrogen is headquartered in Carlsbad, California, and conducts business in more than 70 countries around the world. The company employs approximately 4,700 scientists and other professionals and had revenues of more than $1.15 billion in 2006.

Milestones

edit

• 
  Invitrogen invested in Q Therapeutics . (2/15/08)
  Posted 12/18/09 at 5:45am via qthera.com
• 
  Invitrogen acquired CellzDirect for $57M. (1/10/08)
  Posted 9/10/09 at 3:35pm via fiercebiotech.com

Videos

Screenshots

edit

Sources

1. Invitrogen Announces Acquisition of CellzDirec (fiercebiotech.com) [edit]
2. Q THERAPEUTICS ANNOUNCES SERIES B INVESTMENT (qthera.com) [edit]